These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33506242)

  • 1. Spatiotemporal characteristics of the COVID-19 resurgence in the metropolitan wholesale market of Beijing, China.
    Wang XY; Zhang YQ; Cai LW
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33506242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter from China: Managing the second-wave COVID-19 outbreak in Beijing.
    Xu J; Cao B
    Respirology; 2021 Mar; 26(3):275-276. PubMed ID: 33403736
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China.
    Li X; Wang Q; Ding P; Cha Y; Mao Y; Ding C; Gu W; Wang Y; Ying B; Zhao X; Pan L; Li Y; Chang J; Meng C; Zhou J; Tang Z; Sun R; Deng F; Wang C; Li L; Wang J; MacIntyre CR; Wu Z; Feng Z; Tang S; Xu D
    Sci Total Environ; 2021 Jul; 778():146040. PubMed ID: 33711597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission dynamics and the effects of non-pharmaceutical interventions in the COVID-19 outbreak resurged in Beijing, China: a descriptive and modelling study.
    Cui X; Zhao L; Zhou Y; Lin X; Ye R; Ma K; Jiang JF; Jiang B; Xiong Z; Shi H; Wang J; Jia N; Cao W
    BMJ Open; 2021 Sep; 11(9):e047227. PubMed ID: 34493510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transmission chains of clusters of COVID-19 associated with a market in Beijing].
    Sun YM; Liu F; Cai W; Wang L; Liu F; Li Y; Wang J; Ying H; Fu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Mar; 42(3):427-432. PubMed ID: 34814409
    [No Abstract]   [Full Text] [Related]  

  • 6. Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China.
    Wang X; Pan Y; Zhang D; Chen L; Jia L; Li X; Yang P; Wang Q; Macintyre CR
    BMC Infect Dis; 2020 Jul; 20(1):526. PubMed ID: 32689956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial distribution characteristics of the COVID-19 pandemic in Beijing and its relationship with environmental factors.
    Han Y; Yang L; Jia K; Li J; Feng S; Chen W; Zhao W; Pereira P
    Sci Total Environ; 2021 Mar; 761():144257. PubMed ID: 33352341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COVID-19 pandemic.
    Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in Gansu Province, China: Characteristics, measures, and effects.
    Dong H; Feng L; Zhang N; Zhu Z; Liu X
    J Glob Health; 2021 Jan; 11():03001. PubMed ID: 33643613
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19: The experience from Beijing, China.
    Peng F
    Clin Dermatol; 2021; 39(1):9-11. PubMed ID: 33972058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on the impact of COVID-19 on Chinese small and medium-sized enterprises: Evidence from Beijing.
    Ma Z; Liu Y; Gao Y
    PLoS One; 2021; 16(12):e0257036. PubMed ID: 34882688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.
    Zhao Y; Zhao W; Wang A; Qian F; Wang S; Zhuang L; Zhang F; Sun D; Gao G
    Pediatr Infect Dis J; 2020 Jul; 39(7):e142-e145. PubMed ID: 32404780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is traditional Chinese medicine useful in the treatment of COVID-19?
    Zhang K
    Am J Emerg Med; 2020 Oct; 38(10):2238. PubMed ID: 32245701
    [No Abstract]   [Full Text] [Related]  

  • 14. Spatiotemporal Characteristics and Patterns of the COVID-19 Pandemic in China: An Empirical Study Based on 413 Cities or Regions.
    Shi J; Wang X; Ci F; Liu K
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.
    Wang Y; Tian H; Zhang L; Zhang M; Guo D; Wu W; Zhang X; Kan GL; Jia L; Huo D; Liu B; Wang X; Sun Y; Wang Q; Yang P; MacIntyre CR
    BMJ Glob Health; 2020 May; 5(5):. PubMed ID: 32467353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of patient visits to traditional Chinese medicine during the 2019 coronavirus pandemic.
    Lin SK; Wu CT; Chou HJ; Liu CJ; Ko FY; Huang CH; Lai JN
    BMC Complement Med Ther; 2021 Feb; 21(1):70. PubMed ID: 33607989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital.
    Wang Q; Zhao X; Yue Z; Bai X; Rao H; Han N; Wang T; Wang H; Jiang B
    Emerg Microbes Infect; 2020 Dec; 9(1):2358-2360. PubMed ID: 33054582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of COVID-19 infection in Beijing.
    Tian S; Hu N; Lou J; Chen K; Kang X; Xiang Z; Chen H; Wang D; Liu N; Liu D; Chen G; Zhang Y; Li D; Li J; Lian H; Niu S; Zhang L; Zhang J
    J Infect; 2020 Apr; 80(4):401-406. PubMed ID: 32112886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional Chinese Medicine treatment of COVID-19.
    Xu J; Zhang Y
    Complement Ther Clin Pract; 2020 May; 39():101165. PubMed ID: 32379692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatio-temporal distribution characteristics of COVID-19 in China: a city-level modeling study.
    Ma Q; Gao J; Zhang W; Wang L; Li M; Shi J; Zhai Y; Sun D; Wang L; Chen B; Jiang S; Zhao J
    BMC Infect Dis; 2021 Aug; 21(1):816. PubMed ID: 34391402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.